NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
0.2204
Dollar change
-0.0173
Percentage change
-7.28
%
Index- P/E- EPS (ttm)-18.24 Insider Own36.36% Shs Outstand4.37M Perf Week-25.49%
Market Cap1.05M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.04M Perf Month-75.91%
Enterprise Value-1.02M PEG- EPS next Q- Inst Own2.89% Short Float82.77% Perf Quarter-77.40%
Income-9.85M P/S0.12 EPS this Y- Inst Trans67.36% Short Ratio0.25 Perf Half Y-79.69%
Sales8.79M P/B0.27 EPS next Y- ROA-144.12% Short Interest2.52M Perf YTD-80.14%
Book/sh0.82 P/C0.41 EPS next 5Y- ROE-440.77% 52W High6.61 -96.67% Perf Year-95.60%
Cash/sh0.54 P/FCF- EPS past 3/5Y90.70% 90.39% ROIC-257.06% 52W Low0.21 4.26% Perf 3Y-99.99%
Dividend Est.- EV/EBITDA- Sales past 3/5Y3.33% 9.66% Gross Margin63.18% Volatility6.72% 21.16% Perf 5Y-100.00%
Dividend TTM- EV/Sales-0.12 EPS Y/Y TTM93.72% Oper. Margin-105.83% ATR (14)0.06 Perf 10Y-100.00%
Dividend Ex-Date- Quick Ratio1.59 Sales Y/Y TTM-1.21% Profit Margin-112.07% RSI (14)24.20 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.23 EPS Q/Q96.73% SMA20-40.93% Beta0.28 Target Price11.00
Payout- Debt/Eq0.14 Sales Q/Q2.53% SMA50-69.35% Rel Volume0.19 Prev Close0.24
Employees38 LT Debt/Eq0.07 EarningsMay 13 BMO SMA200-80.87% Avg Volume9.87M Price0.22
IPOFeb 16, 2012 Option/ShortNo / Yes EPS/Sales Surpr.-53.33% -23.84% Trades Volume1,903,724 Change-7.28%
Date Action Analyst Rating Change Price Target Change
Jul-29-24Initiated ROTH MKM Buy $17
Jun-10-25 04:15PM
09:20AM
Jun-09-25 09:15AM
May-14-25 03:10AM
May-13-25 08:15AM
07:00AM Loading…
07:00AM
May-12-25 07:00AM
May-08-25 06:35PM
07:00AM
Apr-30-25 05:50PM
Apr-24-25 07:00AM
Apr-22-25 04:05PM
Apr-21-25 05:02PM
Mar-11-25 08:00AM
Feb-24-25 04:05PM
08:00AM Loading…
Feb-20-25 08:00AM
Feb-18-25 04:15PM
Jan-13-25 08:00AM
Dec-19-24 09:00AM
Nov-11-24 08:00AM
Nov-05-24 09:28AM
Nov-04-24 01:43PM
08:30AM
Nov-01-24 04:15PM
Oct-31-24 08:00AM
Oct-23-24 04:15PM
Sep-25-24 04:15PM
Aug-27-24 09:00AM
Aug-23-24 09:00AM
Aug-13-24 08:00AM
09:00AM Loading…
Aug-08-24 09:00AM
Jul-26-24 09:00AM
Jul-24-24 08:02AM
Jul-23-24 04:10PM
Jul-17-24 09:00AM
Jul-12-24 08:30AM
07:41AM
Jul-09-24 09:00AM
Jun-26-24 08:45AM
Jun-25-24 09:00AM
Jun-06-24 09:00AM
May-14-24 09:00AM
May-09-24 09:00AM
May-07-24 12:53PM
08:00AM
May-02-24 09:00AM
Apr-30-24 06:09PM
04:41PM
Apr-26-24 09:17AM
Apr-09-24 09:00AM
Mar-07-24 09:08AM
Mar-05-24 08:00AM
Feb-27-24 09:00AM
Feb-22-24 07:58AM
Feb-20-24 05:06PM
08:42AM
Feb-06-24 09:00AM
Jan-04-24 03:05PM
Nov-28-23 08:00AM
Nov-14-23 04:30PM
Nov-08-23 01:08PM
Nov-07-23 08:00AM
Nov-01-23 08:00AM
Oct-31-23 08:00AM
Oct-18-23 04:15PM
Oct-17-23 04:15PM
Oct-13-23 08:30AM
Oct-10-23 08:00AM
Sep-11-23 04:15PM
Aug-08-23 08:15AM
08:00AM
Jul-18-23 04:15PM
Jun-20-23 08:30AM
Jun-13-23 04:15PM
Jun-05-23 04:15PM
May-22-23 05:10PM
May-09-23 08:00AM
Apr-18-23 08:00AM
Mar-21-23 08:00AM
Mar-01-23 08:00AM
Feb-28-23 08:00AM
Feb-23-23 04:15PM
08:00AM
Feb-07-23 08:00AM
Jan-09-23 08:00AM
Jan-05-23 02:40PM
Jan-04-23 05:25PM
Dec-29-22 01:35PM
Dec-27-22 04:45PM
Dec-13-22 08:00AM
Dec-08-22 08:10AM
Nov-30-22 08:00AM
Nov-18-22 05:00PM
Nov-08-22 08:00AM
Nov-03-22 07:00AM
Oct-19-22 04:15PM
07:00AM
Oct-18-22 04:15PM
Oct-14-22 08:30AM
Oct-03-22 07:00AM
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.